Literature DB >> 29797537

The role of the maternal and fetal inflammatory response in retinopathy of prematurity.

Anne M Lynch1, Amber A Berning2, Tamara S Thevarajah1, Brandie D Wagner3, Miriam D Post2,4, Emily A McCourt1, Jennifer N Cathcart1, Jennifer K Hodges4, Naresh Mandava1, Ronald S Gibbs5, Alan G Palestine1.   

Abstract

PROBLEM: There is a paucity of research on the contribution of placental inflammation to severe retinopathy of prematurity (ROP). METHOD OF STUDY: A retrospective cohort study (n = 1217) was conducted of infants screened for ROP (2006-2016). The outcomes of the study were severe ROP (type 1 or type 2 ROP) and low grade ROP. We categorized the placental pathology as the presence of (i) maternal plus fetal inflammatory response, (ii) maternal inflammatory response only, (iii) fetal inflammatory response only and, (iv) no evidence of a maternal or fetal inflammatory response. The data were analyzed using univariate and multivariate logistic regression analyses (P < .05).
RESULTS: In this cohort, the number of infants with the maternal plus fetal inflammatory response, the maternal inflammatory response only, the fetal inflammatory response only, and no maternal or fetal inflammatory response was 305 (25%), 82 (7%), 8 (1%), and 822 (67%), respectively. Adjusted for covariates, the maternal plus fetal inflammatory response was a significant risk factor for severe ROP (AOR = 2.6, 95% CI 1.1-5.9, P = .03). None of the categories of placental inflammation were significantly associated with low grade ROP.
CONCLUSION: Placental pathology distinguished by the maternal plus fetal inflammatory response was a significant risk factor for severe ROP. Our study supports a link between intrauterine inflammatory events and the subsequent development of severe ROP.
© 2018 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  fetal inflammatory response; maternal inflammatory response; preterm birth; retinopathy of prematurity; subtypes of preterm birth

Mesh:

Year:  2018        PMID: 29797537     DOI: 10.1111/aji.12986

Source DB:  PubMed          Journal:  Am J Reprod Immunol        ISSN: 1046-7408            Impact factor:   3.886


  6 in total

1.  Association of inflammatory and angiogenic biomarkers in maternal plasma with retinopathy of prematurity in preterm infants.

Authors:  Jae Shin Song; Se Joon Woo; Kyo Hoon Park; Hunmin Kim; Kyong-No Lee; Yu Mi Kim
Journal:  Eye (Lond)       Date:  2022-09-15       Impact factor: 4.456

2.  Prenatal and postnatal inflammation-related risk factors for retinopathy of prematurity.

Authors:  Gregory P Goldstein; Stephanie A Leonard; Peiyi Kan; Euna B Koo; Henry C Lee; Suzan L Carmichael
Journal:  J Perinatol       Date:  2019-04-01       Impact factor: 2.521

Review 3.  Maternal-Fetal Inflammation in the Placenta and the Developmental Origins of Health and Disease.

Authors:  Jeffery A Goldstein; Kelly Gallagher; Celeste Beck; Rajesh Kumar; Alison D Gernand
Journal:  Front Immunol       Date:  2020-11-13       Impact factor: 7.561

4.  Retinopathy of prematurity in Saudi Arabia: Exploring maternal risk factors.

Authors:  Nooran Badeeb; Lina Raffa; Huda AhmedHussain; Dania Bamefleh; Enas Mgharbil; Sarah Alessa; Aliaa Alamri; Mohamed Albahiti
Journal:  Taiwan J Ophthalmol       Date:  2021-01-07

Review 5.  Visuopathy of prematurity: is retinopathy just the tip of the iceberg?

Authors:  Sigrid Hegna Ingvaldsen; Tora Sund Morken; Dordi Austeng; Olaf Dammann
Journal:  Pediatr Res       Date:  2021-06-24       Impact factor: 3.953

6.  Early and late onset sepsis and retinopathy of prematurity in a cohort of preterm infants.

Authors:  Elena Bonafiglia; Elena Gusson; Rosa Longo; Benjamim Ficial; Maria Giulia Tisato; Sara Rossignoli; Giulia Caltran; Emilio Pedrotti; Renzo Beghini; Giorgio Marchini
Journal:  Sci Rep       Date:  2022-07-08       Impact factor: 4.996

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.